journal article
LitStream Collection
Home
Godfrey, Emily M.; Zhang, Ying; Stulberg, Debra B.
doi: 10.1001/jamainternmed.2024.1448pmid: 38739400
This Viewpoint discusses the controversy over mail-order mifepristone prescribed by primary care clinicians for first-trimester abortion as it relates to the history of initial approval, the Supreme Court case Alliance for Hippocratic Medicine v US Food and Drug Administration, and available clinical research.
Tobin-Tyler, Elizabeth; Adashi, Eli
doi: 10.1001/jamainternmed.2024.1652pmid: 38829653
This Viewpoint discusses the dangers to abortion providers and patients of law enforcement access to sexual and reproductive health information.
Zink, Anna; Chernew, Michael E.; Neprash, Hannah T.
doi: 10.1001/jamainternmed.2024.1648pmid: 38805195
This Viewpoint examines artificial intelligence–enabled clinical services, existing payment structures, and the economics of artificial intelligence pricing.
Gaffney, Adam; Woolhandler, Stephanie; Himmelstein, David U.
doi: 10.1001/jamainternmed.2024.1868pmid: 38857031
This Viewpoint makes the case for eliminating Medicare Advantage and doubling down on Traditional Medicare.
doi: 10.1001/jamainternmed.2024.2267pmid: 38913341
This Viewpoint discusses how dentists could provide some primary health care services as part of an interdisciplinary team, easing the burden on clinicians.
doi: 10.1001/jamainternmed.2024.2379pmid: 38884974
This essay describes the importance of physicians using positive reframing with patients.
Grossman, Daniel; Raifman, Sarah; Morris, Natalie; Arena, Andrea; Bachrach, Lela; Beaman, Jessica; Biggs, M. Antonia; Collins, Amy; Hannum, Curtiss; Ho, Stephanie; Seibold-Simpson, Susan M.; Sobota, Mindy; Tocce, Kristina; Schwarz, Eleanor B.; Gold, Marji
Showing 1 to 10 of 45 Articles
Key PointsQuestionIs medication abortion with mail-order pharmacy dispensing of mifepristone effective, acceptable, and feasible? FindingsThis prospective cohort study included 506 participants and 510 medication abortions (≤63 days’ gestation at enrollment) that were provided through mail-order pharmacy dispensing after an in-person eligibility screening; 97.8% were complete abortions and 91.2% of participants reported satisfaction with medication abortion. Serious adverse events were rare (0.6%) and none were associated with mail-order dispensing. MeaningThese findings support the US Food and Drug Administration’s decision to remove the in-person dispensing requirement for mifepristone.